• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利:CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法,用中文像聊天一样搜索,搜遍4000万医学文献。AI智能推荐,让科研检索更轻松。

立即免费搜索

文件翻译

保留排版,准确专业,支持PDF/Word/PPT等文件格式,支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述,25分钟生成高质量综述,智能提取关键信息,辅助科研写作。

立即免费体验

肺部超声作为一种转化方法,用于无创评估心力衰竭小鼠的射血分数降低或保留。

Lung ultrasound as a translational approach for non-invasive assessment of heart failure with reduced or preserved ejection fraction in mice.

机构信息

Centro Nacional de Investigaciones Cardiovasculares Carlos III, Madrid, Spain.

Heart Failure and Inherited Cardiac Diseases Unit, Department of Cardiology, Hospital Universitario Puerta de Hierro, Madrid, Spain.

出版信息

Cardiovasc Res. 2017 Aug 1;113(10):1113-1123. doi: 10.1093/cvr/cvx090.

DOI:10.1093/cvr/cvx090
PMID:28472392
Abstract

AIMS

Heart failure (HF) has become an epidemic and constitutes a major medical, social, and economic problem worldwide. Despite advances in medical treatment, HF prognosis remains poor. The development of efficient therapies is hampered by the lack of appropriate animal models in which HF can be reliably determined, particularly in mice. The development of HF in mice is often assumed based on the presence of cardiac dysfunction, but HF itself is seldom proved. Lung ultrasound (LUS) has become a helpful tool for lung congestion assessment in patients at all stages of HF. We aimed to apply this non-invasive imaging tool to evaluate HF in mouse models of both systolic and diastolic dysfunction.

METHODS AND RESULTS

We used LUS to study HF in a mouse model of systolic dysfunction, dilated cardiomyopathy, and in a mouse model of diastolic dysfunction, diabetic cardiomyopathy. LUS proved to be a reliable and reproducible tool to detect pulmonary congestion in mice. The combination of LUS and echocardiography allowed discriminating those mice that develop HF from those that do not, even in the presence of evident cardiac dysfunction. The study showed that LUS can be used to identify the onset of HF decompensation and to evaluate the efficacy of therapies for this syndrome.

CONCLUSIONS

This novel approach in mouse models of cardiac disease enables for the first time to adequately diagnose HF non-invasively in mice with preserved or reduced ejection fraction, and will pave the way to a better understanding of HF and to the development of new therapeutic approaches.

摘要

目的

心力衰竭(HF)已成为一种流行病,是全球范围内主要的医学、社会和经济问题。尽管医疗技术取得了进步,但 HF 的预后仍然很差。由于缺乏可可靠确定 HF 的合适动物模型(尤其是在小鼠中),高效疗法的开发受到了阻碍。HF 在小鼠中的发展通常基于心脏功能障碍的存在,但很少有证据表明 HF 本身的存在。肺部超声(LUS)已成为评估所有 HF 阶段患者肺部充血的有用工具。我们旨在应用这种非侵入性成像工具来评估收缩和舒张功能障碍的小鼠模型中的 HF。

方法和结果

我们使用 LUS 研究了收缩功能障碍性心肌病和舒张功能障碍性糖尿病心肌病的小鼠模型中的 HF。LUS 被证明是一种可靠且可重复的工具,可用于检测小鼠肺部充血。LUS 和超声心动图的结合可区分那些发生 HF 的小鼠和那些不发生 HF 的小鼠,即使存在明显的心脏功能障碍也是如此。该研究表明,LUS 可用于识别 HF 失代偿的发生,并评估该综合征的治疗效果。

结论

这种在心脏疾病小鼠模型中的新方法首次能够在射血分数保留或降低的小鼠中进行非侵入性 HF 诊断,并为更好地理解 HF 和开发新的治疗方法铺平道路。

相似文献

1
Lung ultrasound as a translational approach for non-invasive assessment of heart failure with reduced or preserved ejection fraction in mice.肺部超声作为一种转化方法,用于无创评估心力衰竭小鼠的射血分数降低或保留。
Cardiovasc Res. 2017 Aug 1;113(10):1113-1123. doi: 10.1093/cvr/cvx090.
2
Assessing congestion in acute heart failure using cardiac and lung ultrasound - a review.使用心肺超声评估急性心力衰竭患者的充血状态——综述。
Expert Rev Cardiovasc Ther. 2021 Feb;19(2):165-176. doi: 10.1080/14779072.2021.1865155. Epub 2021 Jan 12.
3
Combined use of lung ultrasound, B-type natriuretic peptide, and echocardiography for outcome prediction in patients with acute HFrEF and HFpEF.联合使用肺部超声、B 型利钠肽和超声心动图预测急性 HFrEF 和 HFpEF 患者的结局。
Clin Res Cardiol. 2018 Jul;107(7):586-596. doi: 10.1007/s00392-018-1221-7. Epub 2018 Mar 12.
4
A mouse model of heart failure exhibiting pulmonary edema and pleural effusion: Useful for testing new drugs.一种表现出肺水肿和胸腔积液的心力衰竭小鼠模型:对测试新药有用。
J Pharmacol Toxicol Methods. 2019 Mar-Apr;96:78-86. doi: 10.1016/j.vascn.2019.02.001. Epub 2019 Feb 6.
5
Lung ultrasound for the evaluation of pulmonary congestion in outpatients: a comparison with clinical assessment, natriuretic peptides, and echocardiography.肺部超声在外周性肺水肿评估中的应用:与临床评估、利钠肽和超声心动图的比较。
JACC Cardiovasc Imaging. 2013 Nov;6(11):1141-51. doi: 10.1016/j.jcmg.2013.08.004. Epub 2013 Oct 2.
6
Lung ultrasound-guided treatment in ambulatory patients with heart failure: a randomized controlled clinical trial (LUS-HF study).肺部超声引导治疗心力衰竭门诊患者:一项随机对照临床试验(LUS-HF 研究)。
Eur J Heart Fail. 2019 Dec;21(12):1605-1613. doi: 10.1002/ejhf.1604. Epub 2019 Oct 31.
7
Pulmonary congestion evaluated by lung ultrasound predicts decompensation in heart failure outpatients.通过肺部超声评估的肺充血可预测心力衰竭门诊患者的失代偿情况。
Int J Cardiol. 2017 Aug 1;240:271-278. doi: 10.1016/j.ijcard.2017.02.150.
8
Prognostic Value of Dynamic Changes in Pulmonary Congestion During Exercise Stress Echocardiography in Heart Failure With Preserved Ejection Fraction.运动超声心动图中肺充血的动态变化对射血分数保留心力衰竭的预后价值。
Circ Heart Fail. 2020 Jun;13(6):e006769. doi: 10.1161/CIRCHEARTFAILURE.119.006769. Epub 2020 Jun 16.
9
Comparison of left ventricular systolic and diastolic function in patients with idiopathic dilated cardiomyopathy and mild heart failure versus those with severe heart failure.特发性扩张型心肌病合并轻度心力衰竭患者与重度心力衰竭患者左心室收缩和舒张功能的比较。
Am J Cardiol. 2002 Aug 15;90(4):390-4. doi: 10.1016/s0002-9149(02)02495-5.
10
Dynamic changes and prognostic value of pulmonary congestion by lung ultrasound in acute and chronic heart failure: a systematic review.肺部超声评估急性和慢性心力衰竭患者肺淤血的动态变化及其预后价值的系统评价。
Eur J Heart Fail. 2017 Sep;19(9):1154-1163. doi: 10.1002/ejhf.839. Epub 2017 May 30.

引用本文的文献

1
Barth Syndrome: Gene, Cardiologic Aspects, and Mitochondrial Studies-A Comprehensive Narrative Review.巴斯综合征:基因、心脏方面及线粒体研究——一篇全面的叙述性综述
Genes (Basel). 2025 Apr 18;16(4):465. doi: 10.3390/genes16040465.
2
Targeting P21-Activated Kinase 2 as a Novel Therapeutic Approach to Mitigate Endoplasmic Reticulum Stress in Heart Failure With Preserved Ejection Fraction.靶向p21活化激酶2作为减轻射血分数保留的心力衰竭内质网应激的新型治疗方法。
J Am Heart Assoc. 2025 Jan 21;14(2):e035302. doi: 10.1161/JAHA.124.035302. Epub 2025 Jan 10.
3
Targeting lymphatic function in cardiovascular-kidney-metabolic syndrome: preclinical methods to analyze lymphatic function and therapeutic opportunities.
针对心血管-肾脏-代谢综合征中的淋巴功能:分析淋巴功能的临床前方法及治疗机会
Front Cardiovasc Med. 2024 Jun 10;11:1412857. doi: 10.3389/fcvm.2024.1412857. eCollection 2024.
4
The Rat Thoracic Ultrasound protocol: scanning technique and normal findings.大鼠胸部超声检查方案:扫描技术及正常表现
Front Vet Sci. 2024 Feb 19;11:1286614. doi: 10.3389/fvets.2024.1286614. eCollection 2024.
5
Ultrasonographic assessment of pulmonary and Central venous congestion in experimental heart failure.超声评估实验性心力衰竭中的肺和中心静脉充血。
Am J Physiol Heart Circ Physiol. 2024 Feb 1;326(2):H433-H440. doi: 10.1152/ajpheart.00735.2023. Epub 2023 Dec 15.
6
Fibulin-3 is necessary to prevent cardiac rupture following myocardial infarction.纤连蛋白 3 对于预防心肌梗死后的心脏破裂是必要的。
Sci Rep. 2023 Sep 11;13(1):14995. doi: 10.1038/s41598-023-41894-9.
7
Longitudinal CMR assessment of cardiac global longitudinal strain and hemodynamic forces in a mouse model of heart failure.心力衰竭小鼠模型中心脏整体纵向应变和血流动力学力的纵向 CMR 评估。
Int J Cardiovasc Imaging. 2022 Nov;38(11):2385-2394. doi: 10.1007/s10554-022-02631-x. Epub 2022 May 21.
8
Non-invasive assessment of HFpEF in mouse models: current gaps and future directions.无创评估小鼠模型中的 HFpEF:当前的差距和未来的方向。
BMC Med. 2022 Oct 14;20(1):349. doi: 10.1186/s12916-022-02546-3.
9
Heart Failure With Preserved Ejection Fraction: Heterogeneous Syndrome, Diverse Preclinical Models.射血分数保留的心力衰竭:异质性综合征,多种临床前模型。
Circ Res. 2022 Jun 10;130(12):1906-1925. doi: 10.1161/CIRCRESAHA.122.320257. Epub 2022 Jun 9.
10
Spontaneous Degenerative Aortic Valve Disease in New Zealand Obese Mice.新西兰肥胖小鼠的自发性退行性主动脉瓣疾病。
J Am Heart Assoc. 2021 Dec 7;10(23):e023131. doi: 10.1161/JAHA.121.023131. Epub 2021 Nov 15.